Optimal HER2 testing

被引：0

作者：

Viale, Giuseppe ^{[1
,2
]}

机构：

[1] Univ Milan, Sch Med, Dept Pathol, Milan, Italy

[2] Univ Milan, Sch Med, European Inst Oncol, Milan, Italy

来源：

EJC SUPPLEMENTS | 2008年 / 6卷 / 07期

关键词：

D O I：

10.1016/S1359-6349(08)70306-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：31 / 32

页数：2

共 50 条

[1] Advances in HER2 testing
Chen, Yun
Liu, Liang
Ni, Ronghua
Zhou, Weixian
ADVANCES IN CLINICAL CHEMISTRY, VOL 91, 2019, 91 : 123 - 162
[2] Testing for HER2 status
Hanna, W
ONCOLOGY, 2001, 61 : 22 - 30
[3] The HER2 testing conundrum
Allison, Malorye
NATURE BIOTECHNOLOGY, 2010, 28 (02) : 117 - 119
[4] The HER2 testing conundrum
Malorye Allison
Nature Biotechnology, 2010, 28 : 117 - 119
[5] Recommendations for HER2 testing in the UK
Ellis, IO
Dowsett, M
Bartlett, J
Walker, R
Cooke, T
Gullick, W
Gusterson, B
Mallon, E
Lee, PB
JOURNAL OF CLINICAL PATHOLOGY, 2000, 53 (12) : 890 - 892
[6] Emerging technologies for HER2 testing
van de Vijver, M
ONCOLOGY, 2002, 63 : 33 - 38
[7] Testing for HER2 in breast cancer
Lewis, F
Jackson, P
Lane, S
Coast, G
Hanby, AM
HISTOPATHOLOGY, 2004, 45 (03) : 207 - 217
[8] HER2 testing recommendations in Australia
Bilous, M
PATHOLOGY, 2001, 33 (04) : 425 - 427
[9] Guidelines for HER2 testing in the UK
Hsi, ED
Tubbs, RR
JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (03) : 241 - 242
[10] Her2 testing in gastric cancer
Rueschoff, J.
Nagelmeier, I.
Baretton, G.
Dietel, M.
Hoefler, H.
Schildhaus, H. U.
Buettner, R.
Schlake, W.
Stoss, O.
Kreipe, H. H.
PATHOLOGE, 2010, 31 (03): : 208 - +